Search Results - "Rota Scalabrini, Delia"

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned by Viviani, Simonetta, Zinzani, Pier Luigi, Rambaldi, Alessandro, Brusamolino, Ercole, Levis, Alessandro, Bonfante, Valeria, Vitolo, Umberto, Pulsoni, Alessandro, Liberati, Anna Marina, Specchia, Giorgina, Valagussa, Pinuccia, Rossi, Andrea, Zaja, Francesco, Pogliani, Enrico M, Pregno, Patrizia, Gotti, Manuel, Gallamini, Andrea, Scalabrini, Delia Rota, Bonadonna, Gianni, Gianni, Alessandro M

“…BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of…”
Get full text

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial by Mina, Roberto, Falcone, Antonietta Pia, Bringhen, Sara, Liberati, Anna Marina, Pescosta, Norbert, Petrucci, Maria Teresa, Ciccone, Giovannino, Capra, Andrea, Patriarca, Francesca, Rota-Scalabrini, Delia, Bonello, Francesca, Musolino, Caterina, Cea, Michele, Zambello, Renato, Tacchetti, Paola, Belotti, Angelo, Cellini, Claudia, Paris, Laura, Grasso, Mariella, Aquino, Sara, De Paoli, Lorenzo, De Sabbata, Giovanni, Ballanti, Stelvio, Offidani, Massimo, Boccadoro, Mario, Monaco, Federico, Corradini, Paolo, Larocca, Alessandra

Get full text

P804: PLASMA CELL LEUKEMIA‐LIKE TRANSCRIPTOME OF BONE MARROW PLASMA CELLS AND CIRCULATING TUMOR CELL LEVELS IN PERIPHERAL BLOOD COMPLEMENTARILY DEFINE HIGH‐RISK IN NEWLY DIAGNOSED MULTIPLE MYELOMA by D’agostino, Mattia, Bruinink, Davine Hofste Op, Duin, Mark, Rota‐Scalabrini, Delia, Bertamini, Luca, Kuiper, Rowan, Belotti, Angelo, Marasco, Vincenzo, Oliva, Stefania, Rivolti, Elena, Rogers, Jennifer, Mina, Roberto, Grasso, Mariella, Ledda, Antonio, Offidani, Massimo, Galli, Monica, Cavo, Michele, Broijl, Annemiek, Musto, Pellegrino, Bruno, Benedetto, Boccadoro, Mario, Sonneveld, Pieter, Gay, Francesca

Get full text

Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors by Carnevale-Schianca, Fabrizio, Caravelli, Daniela, Gallo, Susanna, Coha, Valentina, D'Ambrosio, Lorenzo, Vassallo, Elena, Fizzotti, Marco, Nesi, Francesca, Gioeni, Luisa, Berger, Massimo, Polo, Alessandra, Gammaitoni, Loretta, Becco, Paolo, Giraudo, Lidia, Mangioni, Monica, Sangiolo, Dario, Grignani, Giovanni, Rota–Scalabrini, Delia, Sottile, Antonino, Fagioli, Franca, Aglietta, Massimo

“…•Post-transplant cyclophosphamide was safely conjugated with 1 of the most-used GVHD prophylaxis regimens.•Nonrelapse mortality was contained to 3% at 2…”
Get full text

Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial by Genuardi, Elisa, Romano, Greta, Beccuti, Marco, Alessandria, Beatrice, Mannina, Donato, Califano, Catello, Rota Scalabrini, Delia, Cortelazzo, Sergio, Ladetto, Marco, Ferrero, Simone, Calogero, Raffaele A., Cordero, Francesca

“…Summary Minimal residual disease (MRD) determined by classic polymerase chain reaction (PCR) methods is a powerful outcome predictor in mantle cell lymphoma…”
Get full text

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial by Bringhen, Sara, D'Agostino, Mattia, Paris, Laura, Ballanti, Stelvio, Pescosta, Norbert, Spada, Stefano, Pezzatti, Sara, Grasso, Mariella, Rota-Scalabrini, Delia, De Rosa, Luca, Pavone, Vincenzo, Gazzera, Giulia, Aquino, Sara, Poggiu, Marco, Santoro, Armando, Gentile, Massimo, Baldini, Luca, Petrucci, Maria Teresa, Tosi, Patrizia, Marasca, Roberto, Cellini, Claudia, Palumbo, Antonio, Falco, Patrizia, Hájek, Roman, Boccadoro, Mario, Larocca, Alessandra

“…n the EMN01 trial, the addition of an alkylator (melphalan or cyclophosphamide) to lenalidomide-steroid induction therapy was prospectively evaluated in…”
Get full text

A prospective, multicenter study on hematopoietic stemcell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents by Mina, Roberto, Petrucci, Maria Teresa, Bonello, Francesca, Bongarzoni, Velia, Saccardi, Riccardo, Bertuglia, Giuseppe, Mengarelli, Andrea, Spadaro, Andrea, Lisi, Chiara, Curci, Paola, Lemoli, Roberto Massimo, Ballanti, Stelvio, Floris, Rita, Cupelli, Luca, Tosi, Patrizia, Olivieri, Attilio, Rota-Scalabrini, Delia, Cangialosi, Clotilde, Nozzoli, Chiara, Anaclerico, Barbara, Fazio, Francesca, Bruno, Benedetto, Mancuso, Katia, Corradini, Paolo, Milone, Giuseppe, Boccadoro, Mario

“…High-dose melphalan plus autologous stem cell transplantation (ASCT) is a standard of care for transplant-eligible patients with newly diagnosed multiple…”
Get full text

Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL) by Zallio, Francesco, Tamiazzo, Stefania, Monagheddu, Chiara, Merli, Francesco, Ilariucci, Fiorella, Stelitano, Caterina, Liberati, Anna Marina, Mannina, Donato, Vitolo, Umberto, Angelucci, Emanuele, Rota Scalabrini, Delia, Vallisa, Daniele, Bellei, Monica, Bari, Alessia, Ciccone, Giovannino, Salvi, Flavia, Levis, Alessandro

“…Summary Survival rates for elderly Hodgkin Lymphoma (HL) have not improved substantially in recent years, mainly because of a lack of prospective randomized…”
Get full text

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage by Ladetto, Marco, De Marco, Federica, Benedetti, Fabio, Vitolo, Umberto, Patti, Caterina, Rambaldi, Alessandro, Pulsoni, Alessandro, Musso, Maurizio, Liberati, Anna M., Olivieri, Attilio, Gallamini, Andrea, Pogliani, Enrico, Scalabrini, Delia Rota, Callea, Vincenzo, Di Raimondo, Francesco, Pavone, Vincenzo, Tucci, Alessandra, Cortelazzo, Sergio, Levis, Alessandro, Boccadoro, Mario, Majolino, Ignazio, Pileri, Alessandro, Gianni, Alessandro M., Passera, Roberto, Corradini, Paolo, Tarella, Corrado

“…In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R)…”
Get full text

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial by Bruna, Riccardo, Benedetti, Fabio, Boccomini, Carola, Patti, Caterina, Barbui, Anna Maria, Pulsoni, Alessandro, Musso, Maurizio, Liberati, Anna Marina, Gini, Guido, Castellino, Claudia, Rossini, Fausto, Ciceri, Fabio, Rota-Scalabrini, Delia, Stelitano, Caterina, Di Raimondo, Francesco, Tucci, Alessandra, Devizzi, Liliana, Zoli, Valerio, Zallio, Francesco, Narni, Franco, Dondi, Alessandra, Parvis, Guido, Semenzato, Gianpietro, Lanza, Francesco, Perrone, Tommasina, Angrilli, Francesco, Billio, Atto, Gueli, Angela, Mantoan, Barbara, Rambaldi, Alessandro, Gianni, Alessandro Massimo, Corradini, Paolo, Passera, Roberto, Ladetto, Marco, Tarella, Corrado

“…A prospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (R-HDS) conventional…”
Get full text

Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells by D’Agostino, Mattia, Rota-Scalabrini, Delia, Belotti, Angelo, Bertamini, Luca, Arigoni, Maddalena, De Sabbata, Giovanni, Pietrantuono, Giuseppe, Pascarella, Anna, Tosi, Patrizia, Pisani, Francesco, Pescosta, Norbert, Ruggeri, Marina, Rogers, Jennifer, Olivero, Martina, Garzia, Mariagrazia, Galieni, Piero, Annibali, Ombretta, Monaco, Federico, Liberati, Anna Marina, Palmieri, Salvatore, Stefanoni, Paola, Zamagni, Elena, Bruno, Benedetto, Calogero, Raffaele Adolfo, Boccadoro, Mario, Musto, Pellegrino, Gay, Francesca

“…Additional copies of chromosome 1 long arm (1q) are frequently found in multiple myeloma (MM) and predict high-risk disease. Available data suggest a different…”
Get full text

Percutaneous Vertebroplasty in Multiple Myeloma: Prospective Long-Term Follow-Up in 106 Consecutive Patients by Anselmetti, Giovanni Carlo, Manca, Antonio, Montemurro, Filippo, Hirsch, Joshua, Chiara, Gabriele, Grignani, Giovanni, Carnevale Schianca, Fabrizio, Capaldi, Antonio, Rota Scalabrini, Delia, Sardo, Elena, Debernardi, Felicino, Iussich, Gabriella, Regge, Daniele

“…Purpose Percutaneous vertebroplasty (PV) is a minimally invasive procedure involving the injection of bone cement within a collapsed vertebral body. Although…”
Get full text

Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors by Carnevale-Schianca, Fabrizio, Caravelli, Daniela, Gallo, Susanna, Becco, Paolo, Paruzzo, Luca, Poletto, Stefano, Polo, Alessandra, Mangioni, Monica, Salierno, Milena, Berger, Massimo, Pessolano, Rosanna, Saglio, Francesco, Gottardi, Daniela, Rota-Scalabrini, Delia, Grignani, Giovanni, Fizzotti, Marco, Ferrero, Ivana, Frascione, Pio Manlio Mirko, D'Ambrosio, Lorenzo, Gaidano, Valentina, Gammaitoni, Loretta, Sangiolo, Dario, Saglietto, Andrea, Vassallo, Elena, Cignetti, Alessandro, Aglietta, Massimo, Fagioli, Franca

“…Combined direct antineoplastic activity and the long-lasting immunological effects of allogeneic hematopoietic cell transplant (HCT) can cure many…”
Get full text

Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study by Iannitto, Emilio, Morabito, Fortunato, Mancuso, Salvatrice, Gentile, Massimo, Montanini, Antonella, Augello, Accursio, Bongarzoni, Velia, D’Arco, Alfonso, Di Renzo, Nicola, Fazzi, Rita, Franco, Giovanni, Marasca, Roberto, Mulè, Antonino, Musso, Maurizio, Musto, Pellegrino, Pennese, Elsa, Piccin, Andrea, Rota‐Scalabrini, Delia, Visani, Giuseppe, Rigacci, Luigi

“…Summary To retrospectively assess the efficacy of bendamustine alone and with rituximab (R–B), 109 patients with relapsed chronic lymphocytic leukaemia (CLL)…”
Get full text

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study by Vitolo, Umberto, Chiappella, Annalisa, Angelucci, Emanuele, Rossi, Giuseppe, Liberati, Anna Marina, Cabras, Maria Giuseppina, Botto, Barbara, Ciccone, Giovannino, Gaidano, Gianluca, Falchi, Lorenzo, Freilone, Roberto, Novero, Domenico, Orsucci, Lorella, Pavone, Vincenzo, Pogliani, Enrico, Rota-Scalabrini, Delia, Salvi, Flavia, Tonso, Anna, Tucci, Alessandra, Levis, Alessandro, on behalf of Gruppo Italiano Multiregionale Linfomi e Leucemie (GIMURELL)

“…1 SC Ematologia II, Azienda Ospedaliera e Universitaria San Giovanni Battista, Torino 2 SC Ematologia, Ospedale Oncologico di Riferimento Regionale Armando…”
Get full text

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial by Gay, Francesca, Musto, Pellegrino, Rota-Scalabrini, Delia, Bertamini, Luca, Belotti, Angelo, Galli, Monica, Offidani, Massimo, Zamagni, Elena, Ledda, Antonio, Grasso, Mariella, Ballanti, Stelvio, Spadano, Antonio, Cea, Michele, Patriarca, Francesca, D'Agostino, Mattia, Capra, Andrea, Giuliani, Nicola, de Fabritiis, Paolo, Aquino, Sara, Palmas, Angelo, Gamberi, Barbara, Zambello, Renato, Petrucci, Maria Teresa, Corradini, Paolo, Cavo, Michele, Boccadoro, Mario

“…Bortezomib-based induction followed by high-dose melphalan (200 mg/m2) and autologous stem-cell transplantation (MEL200-ASCT) and maintenance treatment with…”
Get full text

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma by Bertamini, Luca, Oliva, Stefania, Rota-Scalabrini, Delia, Paris, Laura, Morè, Sonia, Corradini, Paolo, Ledda, Antonio, Gentile, Massimo, De Sabbata, Giovanni, Pietrantuono, Giuseppe, Pascarella, Anna, Tosi, Patrizia, Curci, Paola, Gilestro, Milena, Capra, Andrea, Galieni, Piero, Pisani, Francesco, Annibali, Ombretta, Monaco, Federico, Liberati, Anna Marina, Palmieri, Salvatore, Luppi, Mario, Zambello, Renato, Fazio, Francesca, Belotti, Angelo, Tacchetti, Paola, Musto, Pellegrino, Boccadoro, Mario, Gay, Francesca

“…High levels of circulating tumor plasma cells (CTC-high) in patients with multiple myeloma are a marker of aggressive disease. We aimed to confirm the…”
Get full text

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned by VIVIANI, Simonetta, ZINZANI, Pier Luigi, VALAGUSSA, Pinuccia, ROSSI, Andrea, ZAJA, Francesco, POGLIANI, Enrico M, PREGNO, Patrizia, GOTTI, Manuel, GALLAMINI, Andrea, SCALABRINI, Delia Rota, BONADONNA, Gianni, GIANNI, Alessandro M, RAMBALDI, Alessandro, BRUSAMOLINO, Ercole, LEVIS, Alessandro, BONFANTE, Valeria, VITOLO, Umberto, PULSONI, Alessandro, LIBERATI, Anna Marina, SPECCHIA, Giorgina

Get full text

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma by Larocca, Alessandra, Bonello, Francesca, Gaidano, Gianluca, D'Agostino, Mattia, Offidani, Massimo, Cascavilla, Nicola, Capra, Andrea, Benevolo, Giulia, Tosi, Patrizia, Galli, Monica, Marasca, Roberto, Giuliani, Nicola, Bernardini, Annalisa, Antonioli, Elisabetta, Rota-Scalabrini, Delia, Cellini, Claudia, Pompa, Alessandra, Monaco, Federico, Patriarca, Francesca, Caravita di Toritto, Tommaso, Corradini, Paolo, Tacchetti, Paola, Boccadoro, Mario, Bringhen, Sara

“…Lenalidomide-dexamethasone (Rd) is standard treatment for elderly patients with multiple myeloma (MM). In this randomized phase 3 study, we investigated…”
Get full text

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial by Mina, Roberto, Musto, Pellegrino, Rota-Scalabrini, Delia, Paris, Laura, Gamberi, Barbara, Palmas, Angelo, Aquino, Sara, de Fabritiis, Paolo, Giuliani, Nicola, De Rosa, Luca, Gozzetti, Alessandro, Cellini, Claudia, Bertamini, Luca, Capra, Andrea, Oddolo, Daniela, Vincelli, Iolanda Donatella, Ronconi, Sonia, Pavone, Vincenzo, Pescosta, Norbert, Cea, Michele, Fioritoni, Francesca, Ballanti, Stelvio, Grasso, Mariella, Zamagni, Elena, Belotti, Angelo, Boccadoro, Mario, Gay, Francesca

“…Patients with newly diagnosed multiple myeloma and high-risk cytogenetic abnormalities (HRCA) represent an unmet medical need. In the FORTE trial, lenalidomide…”
Get full text